1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZCCHC3 CTRPv2 pan-cancer AAC 0.17 5e-06
mRNA BORCS7-ASMT CTRPv2 pan-cancer AAC 0.15 5e-06
mRNA WDR7 CTRPv2 pan-cancer AAC 0.16 5e-06
mRNA FBXL19 CTRPv2 pan-cancer AAC 0.15 5e-06
mRNA KRBA2 CTRPv2 pan-cancer AAC 0.15 5e-06
mRNA SRSF11 CTRPv2 pan-cancer AAC 0.15 5e-06
mRNA DAND5 CTRPv2 pan-cancer AAC 0.15 5e-06
mRNA APAF1 CTRPv2 pan-cancer AAC 0.15 6e-06
mRNA ATP2B3 CTRPv2 pan-cancer AAC 0.15 6e-06
mRNA VIMP CTRPv2 pan-cancer AAC -0.15 6e-06
Download CSV